Ovidac 5000 IU Injection (Choriogonadotropin Alpha)

Price range: $206.70 through $532.20Required

United States dollar ($) - USD
  • United States dollar ($) - USD
  • Euro (€) - EUR
  • Canadian dollar ($) - CAD

Pack SizePriceUnit PriceQuantity 
3 Injection$206.70$68.90 / injection
6 Injection$378.00$63.00 / injection
9 Injection$532.20$59.13 / injection
Want to order in bulk / get a B2B price? Send Inquiry

Add $199.00 to cart and get free shipping!

17 People watching this product now!
Estimated delivery: November 12, 2026 – November 17, 2026
Written by Dr Ambrose Chan, MD, MD Medically reviewed by Dr. Sabrina Castillon, MD, MD
Last updated on September 29, 2026
Description

About Ovidac 5000 IU Injection (Choriogonadotropin Alpha)

Medicine information

Active ingredient
Human chorionic gonadotropin (hCG)
Indication
Induction of ovulation in appropriately selected women with anovulatory infertility; selected cases of hypogonadotropic hypogonadism in males. Human chorionic gonadotropin also has established use in selected prepubertal boys with cryptorchidism not caused by anatomical obstruction.
Manufacturer
Bayer Zydus Pharma Private Limited
Packaging
1 mL in 1 vial
Strength
5000 IU
Dosage form
Powder for injection

Medicine overview

Ovidac 5000 IU Injection is an injectable human chorionic gonadotropin (hCG) product containing 5,000 IU. Despite the supplied product description stating “Choriogonadotropin Alpha,” authoritative Indian product records identify Ovidac 5000 IU as human chorionic gonadotropin; it should not be assumed to be the recombinant choriogonadotropin alfa formulation used in products such as Ovidrel. HCG acts similarly to luteinizing hormone (LH) and is used in specific fertility and hormone-related conditions under medical supervision.

What it is used for

In women, hCG can be used to trigger ovulation after appropriate follicular development has been achieved during fertility treatment. In selected males with hypogonadotropic hypogonadism, it stimulates testicular androgen production. Chorionic gonadotropin also has an established indication for selected cases of prepubertal cryptorchidism where there is no anatomical obstruction preventing testicular descent.

How it works

Human chorionic gonadotropin acts in a similar way to luteinizing hormone (LH), a natural reproductive hormone. In women, an LH-like signal can trigger final follicular maturation and ovulation when the ovaries have been appropriately stimulated. In males, hCG acts on Leydig cells in the testes and stimulates androgen, including testosterone, production. This hormonal activity explains its use in selected fertility and hypogonadism treatments.

How it is taken

Ovidac is supplied as an injectable product and should be used according to the prescribed fertility or hormonal treatment protocol. The dose and timing depend on the indication and clinical response. For ovulation induction, ovarian response requires appropriate medical monitoring because the timing of hCG administration is clinically important. The exact administration route for this specific Ovidac presentation could not be verified from an authoritative product-specific prescribing document, so it should not be inferred from another hCG brand.

Important warnings

Do not use hCG in patients with known hypersensitivity to hCG or other human gonadotropins. Important contraindications described for hCG include certain hormone-sensitive tumors, uncontrolled thyroid, adrenal or pituitary disorders, primary gonadal failure in women, reproductive abnormalities incompatible with pregnancy, and unexplained vaginal bleeding. During ovarian stimulation, hCG can contribute to ovarian hyperstimulation syndrome (OHSS), which may become severe or life-threatening. Urgent assessment is needed for severe pelvic or abdominal pain, marked abdominal swelling, persistent nausea or vomiting, rapid weight gain, reduced urination or difficulty breathing. Serious blood clots, ovarian torsion, multiple pregnancy and anaphylaxis have also been reported with gonadotropin therapy.

Side effects and monitoring

Common or recognized effects of hCG include injection-site pain or reactions, headache, fatigue, irritability, restlessness, edema and, in males, gynecomastia. Women receiving ovarian stimulation may develop abdominal discomfort, nausea, ovarian enlargement or OHSS. Rare but serious problems include severe OHSS, thromboembolism, ovarian torsion and systemic hypersensitivity or anaphylaxis. Fertility treatment requires monitoring of ovarian response, commonly using ultrasound and sometimes serum estradiol measurements. Seek urgent medical attention for breathing difficulty, severe abdominal or pelvic pain, rapid weight gain, markedly reduced urination, chest symptoms, signs of a blood clot or a serious allergic reaction.

Pregnancy

HCG is used to help achieve pregnancy in specific fertility protocols but is not generally indicated as ongoing treatment during an established pregnancy. Product labeling for chorionic gonadotropin advises that use after pregnancy is established should follow the specific clinical indication and prescribing information.

Breastfeeding

It is not known whether chorionic gonadotropin is excreted in human milk. Use during breastfeeding therefore requires clinical consideration of the mother's need for treatment and potential effects on the breastfed child.

Storage

Store Ovidac 5000 IU Injection refrigerated at 2°C to 8°C. Do not freeze.

Frequently asked questions

Why do I need an hCG injection at a specific time during fertility treatment?

Timing matters because hCG provides an LH-like hormonal signal that can trigger final follicular maturation and ovulation. Follow the timing given by your fertility specialist rather than changing it yourself.

Can Ovidac cause ovarian hyperstimulation syndrome?

Yes. HCG used with ovarian-stimulation medicines can contribute to ovarian hyperstimulation syndrome (OHSS). Severe abdominal or pelvic pain, rapid weight gain, significant swelling, vomiting, reduced urination or difficulty breathing require prompt medical assessment.

Can an hCG injection make a pregnancy test positive?

Yes. Pregnancy tests detect hCG, so recently administered hCG can interfere with pregnancy testing and may produce a positive result that does not by itself confirm pregnancy. Follow the testing schedule provided by the treating fertility clinic.

Does Ovidac contain the same ingredient as recombinant choriogonadotropin alfa injections such as Ovidrel?

The verified Indian Ovidac 5000 IU product record identifies its ingredient as human chorionic gonadotropin 5,000 IU. It should not be assumed to be interchangeable with a recombinant choriogonadotropin alfa product.

Why are ultrasound scans used when hCG is given for ovulation induction?

Ultrasound helps assess follicular development, determine appropriate timing for the ovulatory trigger and identify excessive ovarian response. Monitoring helps reduce the risk of complications such as OHSS and multiple gestation.

Can hCG injections cause twins or another multiple pregnancy?

Multiple pregnancy is a recognized risk when gonadotropins are used for ovulation induction. Your fertility team monitors ovarian response partly to assess and manage this risk.

Can Cheap Generic Med ship Ovidac internationally?

NOT VERIFIED

Does Ovidac need refrigerated shipping?

The product is stored at 2°C to 8°C and should not be frozen, but a product-specific cold-chain shipping process for Cheap Generic Med is NOT VERIFIED.

Sources

  1. nppa.gov.in
  2. dailymed.nlm.nih.gov
  3. dailymed.nlm.nih.gov
  4. dailymed.nlm.nih.gov

Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.

Additional information
IndicationOvidac 5000 IU triggers the release of a mature egg, helping in
PackagingQty
Delivery Time6 To 15 days
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Ovidac 5000 IU Injection (Choriogonadotropin Alpha)”

Your email address will not be published. Required fields are marked *